| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |